Amakem is a biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) for precision oncology, targeting cancers resistant to current therapies
Amakem is a biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) for precision oncology, targeting cancers resistant to current therapies.